150814-00-9

Basic information

• Product Name: p-vinyl-N-t-butoxycarbonylbenzylamine
• Synonyms: p-vinyl-N-t-butoxycarbonylbenzylamine
• CAS NO: 150814-00-9
• Molecular Weight: 233.31
• Mol File: 150814-00-9.mol
• Article Data: 7

Chemical Properties

• CAS DataBase Reference: p-vinyl-N-t-butoxycarbonylbenzylamine(CAS DataBase Reference)
• NIST Chemistry Reference: p-vinyl-N-t-butoxycarbonylbenzylamine(150814-00-9)
• EPA Substance Registry System: p-vinyl-N-t-butoxycarbonylbenzylamine(150814-00-9)

Safety Data

• Hazardous Substances Data: 150814-00-9(Hazardous Substances Data)

Upstream product

• 24424-99-5 di-tert-butyl dicarbonate 
• 50325-49-0 p-vinylbenzylamine 
• 1228693-05-7 C₂₅H₂₄F₁₇NO₃ 

Downstream Products

• 1245657-05-9 C₇₃H₁₂₄N₁₂O₁₄ 
• 1368807-06-0 tert-butyl 4-[trans-2-(3-methyl-5-phenylisoxazol-4-yl)vinyl]benzylcarbamate 

Relevant articles and documents

Metformin-conjugated micellar system with intratumoral pH responsive de-shielding for co-delivery of doxorubicin and nucleic acid

A novel PMet-P(cdmPEG2K) polymeric micellar carrier was developed for tumor-targeted co-delivery of DOX and nucleic acids (NA), based on polymetformin and a structure designed to lose the PEG shell in response to the acidic extracellular tumor

PRODUCTION METHOD FOR AMIDATE COMPOUND

A method for producing an amidate compound represented by Formula (3), comprising reacting a urethane compound represented by Formula (1) with a carboxylate compound represented by Formula (2): (in the formulas, A, n, R1, R2, R3, R4, R5, R6, X, and a are as described in the Description).

Targeted cutaneous delivery of ciclosporin A using micellar nanocarriers and the possible role of inter-cluster regions as molecular transport pathways

Oral administration of ciclosporin A (CsA) is indicated in the treatment of severe recalcitrant plaque psoriasis. However, CsA is both nephro- and hepatotoxic and its systemic administration also exposes the patient to other severe side effects. Although